Activation of the inflammatory response system in autism

被引:226
作者
Croonenberghs, J
Bosmans, E
Deboutte, D
Kenis, G
Maes, M
机构
[1] Univ Ctr Child & Adolescent Psychiat, Antwerp, Belgium
[2] Eurogenetics, Tessenderlo, Belgium
[3] Acad Hosp Maastricht, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
[4] Clin Res Ctr Mental Hlth, Antwerp, Belgium
[5] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA
[6] Inst Fatebenefratelli, IRCCS, Brescia, Italy
关键词
autism; cytokines; interferon; interleukin-6; immunology;
D O I
10.1159/000048665
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background/Aim: There is now some evidence that autism may be accompanied by abnormalities in the inflammatory response system (IRS). Products of the IRS, such as proinflammatory cytokines, may induce some of the behavioral symptoms of autism, such as social withdrawal, resistance to novelty and sleep disturbances. The main aim of the present study was to examine whether autism is accompanied by an activation of the IRS. Methods: We measured the production of interleukin (IL)-6, IL-10, the IL-1 receptor antagonist (IL-1RA), interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha by whole blood and the serum concentrations of IL-6, the IL-2 receptor (IL-2R) and IL-1RA. Results: This study showed a significantly increased production of IFN-gamma and IL-1RA and a trend toward a significantly increased production of IL-6 and TNF-alpha by whole blood of autistic children. There were no significant differences in the serum concentrations of IL-6, IL-2R and IL-1RA between autistic and normal children. Conclusions: These results suggest that autism may be accompanied by an activation of the monocytic (increased IL-1RA) and Th-1-like (increased IFN-)gamma arm of the IRS. It is hypothesized that increased production of proinflammatory cytokines could play a role in the pathophysiology of autism. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
[1]  
BOCK GR, 1992, CIBA FDN S, V167
[2]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[3]   AUTISM IN CHILDREN WITH CONGENITAL RUBELLA [J].
CHESS, S .
JOURNAL OF AUTISM AND CHILDHOOD SCHIZOPHRENIA, 1971, 1 (01) :33-47
[4]  
CHEUNG DL, 1990, IMMUNOLOGY, V71, P70
[5]   Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders [J].
Connolly, AM ;
Chez, MG ;
Pestronk, A ;
Arnold, ST ;
Mehta, S ;
Deuel, RK .
JOURNAL OF PEDIATRICS, 1999, 134 (05) :607-613
[6]   Cytokines and sickness behavior [J].
Dantzer, R ;
Bluthé, RM ;
Layé, S ;
Bret-Dibat, JL ;
Parnet, P ;
Kelley, KW .
NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 :586-590
[7]  
DAYER JM, 1994, EUR CYTOKINE NETW, V5, P563
[8]   THE NEUROPSYCHIATRIC EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
DENICOFF, KD ;
RUBINOW, DR ;
PAPA, MZ ;
SIMPSON, C ;
SEIPP, CA ;
LOTZE, MT ;
CHANG, AE ;
ROSENSTEIN, D ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) :293-300
[9]   Lymphocyte subsets and interleukin-2 receptors in autistic children [J].
Denney, DR ;
Frei, BW ;
Gaffney, GR .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 1996, 26 (01) :87-97
[10]  
DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517